SCHEMBL425250

SCHEMBL425250

CCOC(=O)C(C(=O)OCC)C(=O)OCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
LMNA P02545 1/20 0.53
HSD17B10 Q99714 1/20 0.53
ALOX15 P16050 1/20 0.50
MGAM O43451 1/20 0.50
GAA P10253 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
SOAT1 P35610 1/20 0.50
TRPA1 O75762 1/20 0.46
PIN1 Q13526 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
MAPT P10636 1/20 0.39
AURKA O14965 1/20 0.39
NTRK1 P04629 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
CAD P27708 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3086153 0.97 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL29262224 0.87 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL123766 0.85 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28163656 0.85 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL26302 0.85 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL662792 0.85 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28436056 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28190143 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL1363735 0.83 SOAT1 (0.48) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL1661987 0.83 CYP1A2 (0.41) ALDH1A1LMNAHSD17B10ALOX15MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087561-A1 RETARDING AGENT IN ISOCYANATE COMPONENT OF POLYURETHANE/UREA CEMENTITIOUS HYBRID SYSTEMS SIKA TECHNOLOGY AG (CH) 2026-04-30 WO claimed
EP-4733284-A1 RETARDING AGENT IN ISOCYANATE COMPONENT OF POLYURETHANE/UREA CEMENTITIOUS HYBRID SYSTEMS Sika Technology AG (CH) 2026-04-29 EP claimed
US-20260035372-A1 METHOD FOR PREPARING (R)-KETOROLAC AND USE THEREOF Yinuoke Medicine Science and Technology Co LTD (CN) 2026-02-05 US claimed
CN-119707793-A Methane trimethyl amide bridged pyridine amide tri-quaternary ammonium salt and preparation method and application thereof 山西大学 2025-03-28 CN claimed
CN-119613316-A Synthesis method of ketorolac key intermediate 鲁南制药集团股份有限公司 2025-03-14 CN claimed
CN-118852853-A Degradable heat-resistant composite material based on cellulose polylactic acid and preparation method thereof 上海汉禾生物新材料科技有限公司 2024-10-29 CN claimed
CN-118580833-A Adhesive and preparation method thereof, negative electrode plate, secondary battery and battery pack 厦门海辰储能科技股份有限公司 2024-09-03 CN claimed
US-20240239042-A9 IN-SITU REACTIVE CURING AND INFILTRATION IN BINDER JET ADDITIVE MANUFACTURING U. S. DEPARTMENT OF ENERGY 2024-07-18 US claimed
CN-115181105-B Preparation method and application of R-ketorolac 长春亿诺科医药科技有限责任公司 2024-05-28 CN claimed
WO-2024041629-A1 PREPARATION METHOD FOR R-TYPE KETOROLAC AND USE THEREOF 长春亿诺科医药科技有限责任公司 2024-02-29 WO claimed
CN-106380407-A Ultralow molecular weight dendritic alkyl hexamine shale inhibitor and synthetic method thereof 西南石油大学 2017-02-08 CN claimed
CN-106120292-A A kind of cashmere goes skin skin processing method 宁夏荣昌绒业集团有限公司 2016-11-16 CN claimed
CN-105542134-A Lactic acid-based aliphatic-aromatic random copolymer CHANGCHUN INST APPLIED CHEMISTRY CAS 2016-05-04 CN claimed
CN-103772677-B A kind of polylactic-acid block copolymer and preparation method thereof CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2015-12-02 CN claimed
CN-103772677-A Polylactic acid segmented copolymer and preparation method thereof CHANGCHUN APPLIED CHEMISTRY 2014-05-07 CN claimed
US-20130041056-A1 POLYMETHACRYLIMIDE FOAM MATERIALS HAVING REDUCED FLAMMABILITY AND METHOD FOR PRODUCING SAME EVONIK ROEHM GMBH (DE) 2013-02-14 US claimed
WO-2006117800-A2 NOVEL 3, 4-PROPYLENEDIOXYTHIOPHENE DERIVATIVES WITH PENDANT FUNCTIONAL GROUPS INDIAN INSTITUTE OF TECHNOLOGY BOMBAY (IN) 2006-11-09 WO claimed
EP-0779267-B1 Process for the preparation of triethyl-3-bromopropane-1,1,1-tricarboxylate GREAT LAKES UK LTD (GB) 2000-03-15 EP claimed
EP-0779267-A1 Process for the preparation of triethyl-3-bromopropane-1,1,1-tricarboxylate THE ASSOCIATED OCTEL COMPANY LIMITED (GB) 1997-06-18 EP claimed
US-5606100-A Process for the preparation of trialkyl ester derivatives LONZA LTD. (CH) 1997-02-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035372-A1 METHOD FOR PREPARING (R)-KETOROLAC AND USE THEREOF SRR, AGL, NOTUM ALDH1A1 683/4885LMNA 474/4885HSD17B10 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.